Telephonic Contact and Subsequent Physical Follow up Treated Lung Cancer Patients (TELE001)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01133067
Recruitment Status : Unknown
Verified July 2014 by J P AGARWAL, Tata Memorial Hospital.
Recruitment status was:  Active, not recruiting
First Posted : May 28, 2010
Last Update Posted : July 28, 2014
Information provided by (Responsible Party):
J P AGARWAL, Tata Memorial Hospital

Brief Summary:
Does the routine clinical practice of follow up after primary treatment in lung cancer patients has any utility.

Condition or disease
Lung Cancer

Detailed Description:
Patients of cancer, after their primary treatment are subsequently called for follow up visits to assess the disease status. This has two important implications from the point of view of resource management. One, patients often have to travel long distances to report to the hospital and have to take care of other logistics such as their accommodation, local travel and food. Further often the patient travels with 1-2 attendants which adds to the logistic burden. Also, these patients of follow up also contribute to the load on existing hospital services. Many authors have speculated that follow-up visits generate anxiety about possible disease recurrence. On the other hand, many others have suggested that although there may be a transient increase in anxiety, patients are ultimately reassured by this practice. Hence, there is no firm evidence for the practice and the need for follow up in oncology care.

Study Type : Observational
Estimated Enrollment : 200 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: A Prospective Study of Telephonic Contact and Subsequent Physical Follow up of Radically Treated Lung Cancer Patients
Study Start Date : July 2010
Actual Primary Completion Date : October 2013
Estimated Study Completion Date : August 2014

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Lung Cancer

Primary Outcome Measures :
  1. Concurrence between the telephonic interview and the physician assessment [ Time Frame: 2 years ]

Secondary Outcome Measures :
  1. Validation of the telephonic questionnaire grand score with the disease free and overall survival [ Time Frame: 2 years ]
  2. Cost analysis [ Time Frame: 2 years ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 90 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
All curative lung cancer patients after there intial primary treatment who have already been given scheduled appointment shall be called telephonically every 3 months. A set of questions shall be asked to the patient in his /her vernacular during the telephonic interview.After the telephonic interview, the patients shall then report to the cancer care specialist at the Hospital for the due follow up visit.

Inclusion Criteria:

  1. All patients of lung cancer treated with a radical aim (e.g surgery, Chemoradiation, surgery followed by adjuvant treatment or any other combination)
  2. Patients should have completed radical /adjuvant treatment, if any
  3. Patients of both SCLC and NSCLC
  4. Patients with at least two telephone numbers (landline/mobile/both)
  5. Patients willing to participate

Exclusion Criteria:

  1. All patients for palliative intention
  2. Patients with less than two contact telephone numbers -

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01133067

Tata Memorial Hospital
Mumbai, MS, India, 400012
Sponsors and Collaborators
Tata Memorial Hospital
Principal Investigator: JP AGARWAL, MD Tata Memorial Hospital

Responsible Party: J P AGARWAL, Professor Radiation Oncology, Tata Memorial Hospital Identifier: NCT01133067     History of Changes
Other Study ID Numbers: PROJECT NO 754
First Posted: May 28, 2010    Key Record Dates
Last Update Posted: July 28, 2014
Last Verified: July 2014

Keywords provided by J P AGARWAL, Tata Memorial Hospital:
lung cancer
physical follow up
telephonic followup

Additional relevant MeSH terms:
Lung Neoplasms
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Lung Diseases
Respiratory Tract Diseases